- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT04985175
Impact of Decision Quality by Using Question Prompt List
1 augusti 2021 uppdaterad av: National Taiwan University Hospital
Impact of Decision Quality by Using Question Prompt List on the Shared Decision Making in End-stage Renal Disease Patients
To investigate the effects of a question prompt list (QPL) on a shared decision-making consultation among facing decision for dialysis in end-stage renal disease (ESRD) patients.
A randomized controlled trial was conducted at the university medical center of North Taiwan.
Subjects were randomized assigned to QPL group or usual care group.
Decisional quality and decision control preferences were assessed with questionnaires.
Measurements were performed at before the counseling (T0), immediately after counseling (T1), and evaluate decision regret at one month after treatment.
Studieöversikt
Status
Anmälan via inbjudan
Betingelser
Intervention / Behandling
Detaljerad beskrivning
The aim of this study was to investigate the effectiveness of decisional quality and decisional control preferences by using a specific question prompt list (QPL) during a shared decision-making consultation among facing decision for dialysis in end-stage renal disease (ESRD) patients.
A randomized controlled trial was conducted at the university medical center of North Taiwan.
Recruit subjects are those who are about to receive the nurse-led coaching of shared decision-making (SDM) for patients with ESRD and attend the program.
By using blocked Randomization design, the investigators assigned participants to QPL group or usual care.
Prior to a clinic visit to discuss treatment, two-pages ESRD QPL leaflets are provided to QPL group, while usual care group without receiving provision of QPL.
Measurements of outcome included decision quality (decision conflict, decisional self-efficiency) and decision control preference at before the counseling (T0), immediately after counseling (T1), and evaluate decision regret at one month after treatment (T2), at this time the patient has decided and started to accept the selected treatment (hemodialysis, peritoneal dialysis or conservative treatment).
All statistical analyses were performed in SAS statistical software, version 9.4 (SAS, Cary, NC).
The effects of the intervention were assessed by generalized estimating equation (GEE) analysis with the coefficient of interaction ( group × time) term.
Statistical tests were two-sided with a significance level of 0.05.
Hierarchical Linear Model was used to detect the impact of nested within physician.
Studietyp
Interventionell
Inskrivning (Förväntat)
154
Fas
- Inte tillämpbar
Kontakter och platser
Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.
Studieorter
-
-
Xindian
-
Taipei City, Xindian, Taiwan, 231
- National Taiwan University Hospital
-
-
Deltagandekriterier
Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.
Urvalskriterier
Åldrar som är berättigade till studier
20 år och äldre (Vuxen, Äldre vuxen)
Tar emot friska volontärer
Nej
Kön som är behöriga för studier
Allt
Beskrivning
Inclusion Criteria:
- Patients with stage 5 chronic kidney disease who facing decision for dialysis;
- normal cognitive functions;
- be able to read, communicate in Mandarin or Taiwanese;
- ability to express willingness;
Exclusion Criteria:
- vision or hearing function impairment;
- Severe illness;
- Urgent to dialysis for extend life;
- Dialysis modalities Already decided.
Studieplan
Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Stödjande vård
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: QPL group
receive 2-pages ESRD QPL leaflets, circle the questions they want to ask before consultation.
encourage asking questions with doctor during consultation.
receive the nurse-led coaching of shared decision-making (SDM)
|
The specific QPS was a one page leaflet for chronic kidney disease which developed by applied literature and public QPL from the National Health Agency.
It contains 3 domains 25 questions related to treatment, dialysis, and Kidney transplant.
The QPL group participants were asked to read and mark those questions they concerned or write down additional problems.
|
|
Inget ingripande: Usual care group
without receiving provision of QPL encourage asking questions with doctor during consultation.
receive the nurse-led coaching of shared decision-making (SDM)
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Decision conflict
Tidsram: before the counseling (T0), immediately after counseling(T1)
|
Decision conflict was measured by Decision conflict scale(DCS).
The scale consists of 16 items into 5 subscales: Uncertainty(3 items), Informed(3 items), values clarity(3 items), support(3 items), and effective decision(4 items) that are rated on a 5-point likert-scale from "strongly agree" (0) to "strongly disagree" (4).
The sum of scores are calculated from 0 to 100.
The higher the score, the higher the level of decision conflict.
|
before the counseling (T0), immediately after counseling(T1)
|
|
Decisional self-efficiency
Tidsram: before the counseling (T0), immediately after counseling(T1)
|
Decision self-efficiency was measured by Decisional Self-Efficiency Scale(DSES).
The scale represents self-confidence or belief in decision making.
The scale consists of 11 items that are rated on a 5-point likert-scale from "not at all confident" (0) to" very confident "(4) .
The sum of scores are calculated from 0 to 100.
The higher the score, the higher the level of self-confidence.
|
before the counseling (T0), immediately after counseling(T1)
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Decision control preference
Tidsram: one month after treatment (T2)
|
Decision regret was measured by Decision regret Scale(DRS) .The scale consists of 5 items that are rated on a 5-point likert-scale from "strongly agree "(1) to" strongly disagree" (5) .
The sum of scores are calculated from 0 to 100.
The higher the score, the higher the level of regret.
|
one month after treatment (T2)
|
|
Decision control preference
Tidsram: before the counseling (T0), immediately after counseling(T1)
|
Decision control preference was measured by Decision control preference Scale(DCPS) .The scale asks two question:(1)control preference measured at before the counseling; (2) actual decision control level measured after counseling immediately.
|
before the counseling (T0), immediately after counseling(T1)
|
Samarbetspartners och utredare
Det är här du hittar personer och organisationer som är involverade i denna studie.
Studieavstämningsdatum
Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.
Studera stora datum
Studiestart (Förväntat)
15 augusti 2021
Primärt slutförande (Förväntat)
30 juni 2022
Avslutad studie (Förväntat)
31 augusti 2022
Studieregistreringsdatum
Först inskickad
26 juli 2021
Först inskickad som uppfyllde QC-kriterierna
26 juli 2021
Första postat (Faktisk)
2 augusti 2021
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
9 augusti 2021
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
1 augusti 2021
Senast verifierad
1 maj 2021
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 202104009RINA
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Nej
Studerar en amerikansk FDA-reglerad produktprodukt
Nej
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .